Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has been struggling during the past year. Its financial results - ...

One such example is Novo Nordisk (NYSE: NVO), the Denmark-based pharmaceutical leader whose shares are exchanging hands for ...

An elderly American man has become completely blind after he was prescribed to take Ozempic to manage his type 2 diabetes.

Shares in Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, ...

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Denmark and Japan to develop floating wind turbines, police warning over scam tickets, new Danish-made online infobot and ...

The global capability centre of Novo Nordisk in India is now closely engaged with the entire value chain of this global ...

Novo Nordisk clarifies Human Mixtard penfill to be replaced with injectables: Our Bureau, Bengaluru Wednesday, April 23, 2025, 13:30 Hrs [IST] Denmark-based global pharma major, N ...

Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why ...

some uncertainty remains along with the risk of disruptions for Novo Nordisk as tariffs will increase prices. The company's key manufacturing facility is still in Denmark, though it does produce ...